Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982;13(Suppl 2):167S–174S. doi: 10.1111/j.1365-2125.1982.tb01906.x

Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.

J F Giudicelli, F Lhoste
PMCID: PMC1402132  PMID: 6125166

Abstract

1 Atrio-ventricular conduction and its modifications induced by six beta-adrenoceptor blocking agents and isoprenaline have been investigated in the anaesthetized dog using the extrastimulus technique and measuring atrial (AERP), nodal (NERP), global (GERP) effective refractory periods as well as global functional refractory period (GFRP). 2 When beta-adrenoceptor blockade was produced by (+/-)-propranolol (beta 1 + beta 2-adrenoceptor blockade) which is devoid of intrinsic sympathomimetic activity (ISA) but has membrane stabilizing effects (MSE), sotalol (beta 1 + beta 2-adrenoceptor blockade, no ISA, no MSE) and atenolol (beta 1-adrenoceptor blockade, no ISA, no MSE), all parameters were significantly increased. When beta-adrenoceptor blockade was achieved with pindolol (beta 1 + beta 2-adrenoceptor blockade) and practolol (beta 1-adrenoceptor blockade) which have ISA but no MSE, all parameters remained unchanged, as was also the case with (+)-propranolol, which has MSE but neither ISA nor beta-adrenolytic properties. 3 Isoprenaline at high doses significantly reduced the refractory periods but when infusion was stopped, marked but reversible conduction depression was observed. 4 It thus appears that beta-adrenoceptor blockade but not MSE is responsible for the onset of atrial and AV-conduction impairment and that ISA affords protection against this impairment.

Full text

PDF
167S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett A. M., Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970 Nov;40(3):373–381. doi: 10.1111/j.1476-5381.1970.tb10619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett A. M., Carter J., Fitzgerald J. D., Hull R., Le Count D. A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol. 1973 Jun;48(2):340P–340P. [PMC free article] [PubMed] [Google Scholar]
  3. Childers R. W., Merideth J., Moe G. K. Supernormality in Bachmann's bundle. An in vitro and in vivo study in the dog. Circ Res. 1968 Mar;22(3):363–370. doi: 10.1161/01.res.22.3.363. [DOI] [PubMed] [Google Scholar]
  4. Denes P., Wu D., Dhingra R., Pietras R. J., Rosen K. M. The effects of cycle length on cardiac refractory periods in man. Circulation. 1974 Jan;49(1):32–41. doi: 10.1161/01.cir.49.1.32. [DOI] [PubMed] [Google Scholar]
  5. Dunlop D., Shanks R. G. Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968 Jan;32(1):201–218. doi: 10.1111/j.1476-5381.1968.tb00444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frishman W., Silverman R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects. Am Heart J. 1979 Jun;97(6):797–807. doi: 10.1016/0002-8703(79)90016-4. [DOI] [PubMed] [Google Scholar]
  7. Giudicelli J. F., Lhoste F., Boissier J. R. Beta-adrenergic blockade and atrio--ventricular conduction impairment. Eur J Pharmacol. 1975 Apr;31(2):216–225. doi: 10.1016/0014-2999(75)90042-4. [DOI] [PubMed] [Google Scholar]
  8. Giudicelli J. F., Schmitt H., Boissier J. R. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther. 1969 Jul;168(1):116–126. [PubMed] [Google Scholar]
  9. Howe R., Shanks R. G. Optical isomers of propranolol. Nature. 1966 Jun 25;210(5043):1336–1338. doi: 10.1038/2101336a0. [DOI] [PubMed] [Google Scholar]
  10. KRAYER O., MANDOKI J. J., MENDEZ C., RUBIO G. R. Studies on veratrum alkaloids. XVI. The action of epinephrine and of veratramine on the functional refractory period of the auriculo-ventricular transmission in the heart-lung preparation of the dog. J Pharmacol Exp Ther. 1951 Dec;103(4):412–419. [PubMed] [Google Scholar]
  11. Kassebaum D. G., Van Dyke A. R. Electrophysiological effects of isoproterenol on Purkinje fibers of the heart. Circ Res. 1966 Nov;19(5):940–946. doi: 10.1161/01.res.19.5.940. [DOI] [PubMed] [Google Scholar]
  12. Koch-Weser J., Frishman W. H. beta-Adrenoceptor antagonists: new drugs and new indications. N Engl J Med. 1981 Aug 27;305(9):500–506. doi: 10.1056/NEJM198108273050907. [DOI] [PubMed] [Google Scholar]
  13. Lau S. H., Bobb G. A., Damato D. N. Catheter recording and validation of left bundle-branch potentials in intact dogs. Circulation. 1970 Sep;42(3):375–383. doi: 10.1161/01.cir.42.3.375. [DOI] [PubMed] [Google Scholar]
  14. Levy J. V. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties. Eur J Pharmacol. 1968 Feb;2(4):250–257. doi: 10.1016/0014-2999(68)90074-5. [DOI] [PubMed] [Google Scholar]
  15. Lhoste F., Giudicelli J. F., Boissier J. R. Isoprenaline and canine cardiac refractory periods. Eur J Pharmacol. 1976 Sep;39(1):171–177. doi: 10.1016/0014-2999(76)90125-4. [DOI] [PubMed] [Google Scholar]
  16. Lucchesi B. R., Whitsitt L. S., Stickney J. L. Antiarrhythmic effects of beta adrenergic blocking agents. Ann N Y Acad Sci. 1967 Feb 10;139(3):940–951. doi: 10.1111/j.1749-6632.1967.tb41262.x. [DOI] [PubMed] [Google Scholar]
  17. MOE G. K., PRESTON J. B., BURLINGTON H. Physiologic evidence for a dual A-V transmission system. Circ Res. 1956 Jul;4(4):357–375. doi: 10.1161/01.res.4.4.357. [DOI] [PubMed] [Google Scholar]
  18. Nakano J., Kusakari T. Effect of beta adrenergic blockade on the cardiovascular dynamics. Am J Physiol. 1966 Apr;210(4):833–837. doi: 10.1152/ajplegacy.1966.210.4.833. [DOI] [PubMed] [Google Scholar]
  19. Narula O. S., Javier R. P., Samet P., Maramba L. C. Significance of His and left bundle recordings from the left heart in man. Circulation. 1970 Sep;42(3):385–396. doi: 10.1161/01.cir.42.3.385. [DOI] [PubMed] [Google Scholar]
  20. Nayler W. G., Chipperfield D., Lowe T. E. The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle. Cardiovasc Res. 1969 Jan;3(1):30–36. doi: 10.1093/cvr/3.1.30. [DOI] [PubMed] [Google Scholar]
  21. Puech P., Grolleau R., Latour H., Dufoix R., Cabasson J., Robin J. Enregistrement de l'activité de la branche gauchedu faisceau e His par voie endocavitaire. Arch Mal Coeur Vaiss. 1971 Jan;64(1):10–26. [PubMed] [Google Scholar]
  22. Rosen K. M., Rahimtoola S. H., Sinno M. Z., Gunnar R. M. Bundle branch and ventricular activation in man: a study using catheter recordings of left and right bundle branch potentials. Circulation. 1971 Feb;43(2):193–203. doi: 10.1161/01.cir.43.2.193. [DOI] [PubMed] [Google Scholar]
  23. Scales B., McIntosh D. A. Effects of propranolol and its optical isomers on the radiocalcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF). J Pharmacol Exp Ther. 1968 Apr;160(2):261–267. [PubMed] [Google Scholar]
  24. Singh B. N., Vaughan Williams E. M. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol. 1970 Aug;39(4):675–687. doi: 10.1111/j.1476-5381.1970.tb09893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Waal-Manning H. J. Hypertension: which beta-blocker? Drugs. 1976 Dec;12(6):412–414. doi: 10.2165/00003495-197612060-00002. [DOI] [PubMed] [Google Scholar]
  26. Wale J., Pun L. Q., Rand M. J. The effects of ICI 50172, propranolol, pronethalol and MJ 1999 on beta-receptors. Eur J Pharmacol. 1969 Oct;8(1):25–35. doi: 10.1016/0014-2999(69)90125-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES